Press Releases
 
Aus and NZ oncologists can provide personalised cancer treatments using Caris Molecular Intelligence

, 13 November 2017 -- Caris Life Sciences provides the most comprehensive genomic tumour profiling plus (CGP+) of DNA, RNA and proteins enabling personalised therapy decisions across immunotherapy, targeted therapy and chemotherapy.

Caris Life Sciences provides the most comprehensive genomic tumour profiling plus (CGP+) of DNA, RNA and proteins enabling personalised therapy decisions across immunotherapy, targeted therapy and chemotherapy. Since its foundation in 2008 Caris has collected clinical outcomes that show the superiority of CMI.1,2

Precision Oncology is proud to be the new exclusive distributor for Caris Molecular Intelligence in Australia and New Zealand.

More than 6,000 oncologists from 58 countries have used Caris Life Sciences to profile more than 120,000 tumours worldwide. With Caris Molecular Intelligence and the very latest cancer target (biomarker) research, increasing numbers of oncologists are choosing the treatments that are likely to work for each patient’s cancer.

Better information can lead to better treatment decisions

Standard cancer treatment is based largely on the original location of the tumour, such as the breast or lungs. This approach may not always produce optimal results.

In contrast, Caris Molecular Intelligence matches evidence-guided cancer treatments with the molecular profile of each tumour. A molecular profile reveals the unique characteristics of a person’s cancer at the molecular level, providing doctors with knowledge about which treatments are most likely to produce the best results, including treatments that may not have been previously considered. Molecular profiling may also help doctors avoid treatments that are ineffective, unnecessary, and potentially harmful.

Molecular profiling provides the information that helps oncologists to personalise treatment plans for individual patients. It can be particularly valuable for people who have run out of standard treatment options, for those with rare or aggressive cancer, or if there are multiple treatment options available for that type of cancer.

To find out more about how Caris Molecular Intelligence can help oncologists and patients, contact Precision Oncology today.

References

1. Capdevila J, Rojo F, Gonzalez-Martin A, et al. Molecular profiling for clinical decision making in advanced cancer: a clinical appraisal. Journal of Cancer Research and Treatment. 2017; 5(3): 77-85. [Full text]

2. Ussia G, Leonard R, Janssens J. Multi-platform tumour profiling delivers the highest clinical utility and improves patient outcomes in today’s routine clinical practice. International Journal of Surgery & Surgical Procedures. 2016, 1: 107. [Full text]

Contact
Elizabeth Tysoe, General Manager
Company: Precision Oncology
Address: Subiaco, Western Australia, Australia
Phone: +61 8 6245 2020
Email:
Website: https://www.precisiononcology.com.au/

# # #


Submitted by suleman, suleman on Monday, 13 November 2017 at 7:50 PM
Category: Health Care & Medical
 
Related News

Get Dental Implants In Austin, TX
Saturday, 24 Feb 2018

Global Lymphoblastic Lymphoma Clinical Trials Market Outlook to 2017: Ken Research
Friday, 23 Feb 2018

Lymphedema Global Clinical Trials Review H2 2017: Ken Research
Friday, 23 Feb 2018

Rheumatology Therapeutics Market will Rise at a Lackluster CAGR of 2.7% from 2017 to 2025
Friday, 23 Feb 2018

General Surgery Devices Market : Competitive Landscape Analysis with Forecast by 2025
Friday, 23 Feb 2018

Related Events

Winter Wilderness First Aid Certification - Colorado
Friday, 23 Feb 2018

Collaborative 3D Printing in Medical Practice
Friday, 23 Feb 2018

The Great Plains Laboratory Presents GPL Academy Practitioner Workshops
Saturday, 24 Feb 2018

The National Conference on Wilderness Medicine Big Sky Winter
Saturday, 24 Feb 2018

Neuroepigenetics and Neuroepitranscriptomics Conference, Mexico, 2018
Saturday, 24 Feb 2018

Latest News

Search For Restaurants In Killeen, TX
Saturday, 24 Feb 2018

Ripple Side Office Rental Offering Virtual Office Space on Rent
Saturday, 24 Feb 2018

North Geelong Glass – Best Options for Window Repairing
Saturday, 24 Feb 2018

Mazda Dealers - A Mazda Selection is the Correct 1
Saturday, 24 Feb 2018

Buy the Best Workout Benches Online
Saturday, 24 Feb 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Saturday, 24 February 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Winter Wilderness First Aid Certification - Colorado
  • Collaborative 3D Printing in Medical Practice
  • The Great Plains Laboratory Presents GPL Academy Practitioner Workshops
  • The National Conference on Wilderness Medicine Big Sky Winter
  • Neuroepigenetics and Neuroepitranscriptomics Conference, Mexico, 2018

  • Latest Jobs
    Sorry, there are currently no entries posted here.